Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albiglutide vs Pioglitazone or Placebo in T2DM (HARMONY 5)
NCT00839527Phase 3Completed
- Sponsor
- GSK
- Start
- Feb 2009
- Primary completion
- Jan 2012
- Modality
- Fc-Fusion Proteins
- Countries
- 9
01
Overview
A Phase 3 trial of albiglutide in type 2 diabetes mellitus (T2DM), sponsored by GSK. Started Feb 2009; status: completed.
02
Drugs
albiglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00839527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00839527.